All subjects have now been enrolled in Island Pharmaceutical’s phase 2b arm of its ISLA-101 trial in dengue fever. Don't miss out on the headlines from Stockhead. Followed categories will be added to ...

All subjects enrolled in Island Pharmaceutical’s phase 2b arm of phase 2a/b PROTECT trial of ISLA-101 in dengue fever Phase 2b study will explore ability of ISLA-101 to reduce symptoms of a ...

Special Report: Australian antiviral drug development company Island Pharmaceuticals has kicked off the phase 2b clinical trial of lead drug ISLA-101 in dengue fever with the first subjects ...

All subjects have now been enrolled in Island Pharmaceutical’s phase 2b arm of its ISLA-101 trial in dengue fever. Don't miss out on the headlines from Stockhead. Followed categories will be ...